Eyal Fenig

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines

M. Bakhanashvili, J. Sandbank, R. Yerushalmi, 2005, British Journal of Cancer.